Credit Suisse’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-25
| Closed | – | – | 4336 |
|
|
2022
Q2 | $0 | Buy |
+25
| New | – | ﹤0.01% | 4374 |
|
|
2021
Q1 | – | Sell |
-13,147
| Closed | -$63K | – | 3587 |
|
|
2020
Q4 | $63K | Buy |
+13,147
| New | +$63K | ﹤0.01% | 3373 |
|
|
2018
Q3 | – | Sell |
-12,840
| Closed | -$48K | – | 3445 |
|
|
2018
Q2 | $48K | Buy |
+12,840
| New | +$48K | ﹤0.01% | 3441 |
|
|
2018
Q1 | – | Sell |
-16,518
| Closed | -$97K | – | 3591 |
|
|
2017
Q4 | $97K | Buy |
+16,518
| New | +$97K | ﹤0.01% | 3343 |
|
|
2017
Q3 | – | Sell |
-55,381
| Closed | -$211K | – | 3738 |
|
|
2017
Q2 | $211K | Buy |
+55,381
| New | +$211K | ﹤0.01% | 3217 |
|
|
2017
Q1 | – | Sell |
-11,271
| Closed | -$37K | – | 3638 |
|
|
2016
Q4 | $37K | Sell |
11,271
-111
| -1% | -$364 | ﹤0.01% | 3681 |
|
|
2016
Q3 | $34K | Sell |
11,382
-740
| -6% | -$2.21K | ﹤0.01% | 3699 |
|
|
2016
Q2 | $50K | Buy |
+12,122
| New | +$50K | ﹤0.01% | 3841 |
|